Figure 1.
Treatment schedule. Drugs, doses, and plan of induction and consolidation phases. Intrathecal chemotherapy was delivered weekly in patients with meningeal disease. Methotrexate dose on day 21 was 5 g/m2 in HIV-positive patients. Graphic represents consolidation phase for HIV− patients. Consolidation phase for HIV+ patients is reported in Table 1.

Treatment schedule. Drugs, doses, and plan of induction and consolidation phases. Intrathecal chemotherapy was delivered weekly in patients with meningeal disease. Methotrexate dose on day 21 was 5 g/m2 in HIV-positive patients. Graphic represents consolidation phase for HIV− patients. Consolidation phase for HIV+ patients is reported in Table 1.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal